Dr. Tiago Reis Marques
Board Member
Pasithea Therapeutics Corp. (KTTA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Tiago Reis Marques
Dr. Tiago Reis Marques is recorded as CEO and Board Member at Pasithea Therapeutics Corp. (KTTA). The proxy statement of Pasithea Therapeutics Corp. reports total compensation of $1,327,518 for Dr. Tiago Reis Marques in fiscal 2025, including a base salary of $533,610. Disclosed compensation is on record for 6 fiscal years. Dr. Tiago Reis Marques has spoken on 1 investor event across 1 company, most recently for Pasithea Therapeutics Corp. on September 9, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Pasithea Therapeutics Corp.
Other people whose current roles at this company are on record from its filings.
- Prof. Lawrence Steinman Chairman
- Daniel Schneiderman CFO
- Dr. Yassine Bendiabdallah COO
- Alfred J. Novak Board Member
- Alfred Novak Board Member
- Dr. Emer Leahy Board Member
- Emer Leahy Board Member
- Lawrence Steinman Board Member
- Simon Dumesnil Board Member
- Tiago Reis Marques Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | $533,610 | $1,327,518 |
| 2024 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | $450,000 | $640,059 |
| 2023 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | $450,000 | $537,347 |
| 2022 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | $450,000 | $539,250 |
| 2021 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | $243,750 | $671,891 |
| 2020 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.